IRMD
Iradimed·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one analyst, yet historical win rate is 0.0%, limiting conviction. Fund flow is positive with a 7.51/10 score, where Small-size flows show a positive trend despite overall negative flow. This suggests institutional accumulation may be underway, but the lack of broader analyst coverage keeps the outlook tentative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-02-14
InstitutionRoth MKM
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of IRMD?
- IRMD holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
